Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05370014 · ClinicalTrials.gov registry record · NA
Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads
A NA study of Stroke and Diabetes Mellitus, Type 2, sponsored by University of South Carolina.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT05370014: Recruiting NA study of Stroke and Diabetes Mellitus, Type 2, sponsored by University of South Carolina.
NCT05370014 is a NA study of Stroke and Diabetes Mellitus, Type 2 that is actively recruiting participants, run by University of South Carolina. The registered enrollment target is 500 participants, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05370014, a NA study of Stroke and Diabetes Mellitus, Type 2, is actively recruiting participants, sponsored by University of South Carolina.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study tests the efficacy of a dyadic intervention to mitigate the adverse health consequences of severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2 )(COVID-19) in African American (AA) adults with pre-existing chronic health conditions and their informal carepartners (IC). Socioeconomically disadvantaged, older, and Black/African American from rural regions are burdened with greater rates of chronic diseases such as diabetes, hypertension, chronic kidney disease, cardiovascular disease, and stroke.
Primary Outcome
Quality of Life 10 items. minimum score 4 to maximum score 20. Higher scores mean better.
Conditions Studied
Interventions
- BEHAVIORAL Integrating Community-based Intervention Under Nurse Guidance with Families (iCINGS FAM)
Study Locations (1)
South Carolina
- University of South Carolina - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-01-03 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT05370014 shows while recruiting
NCT05370014 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (96% lower).
The record links to 6 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Integrating Community-based Intervention Under Nurse Guidance with Families (iCINGS FAM) is the first listed.
NCT05370014 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT05370014 about?
NCT05370014 is a clinical study titled "Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads". This study tests the efficacy of a dyadic intervention to mitigate the adverse health consequences of severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2 )(COVID-19) in African American (AA) adults with pre-existing chronic health conditions and their informal carepartners (IC). Socioeconom...
What is the current status of trial NCT05370014?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2023-01-03. Estimated completion is 2026-06-30.
What conditions does trial NCT05370014 study?
This clinical trial studies the following conditions: Stroke, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Chronic Kidney Diseases, Chronic Disease.
What interventions are being tested in trial NCT05370014?
The interventions under investigation include: Integrating Community-based Intervention Under Nurse Guidance with Families (iCINGS FAM) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05370014?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05370014 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05370014's enrollment target sits among peer trials
500 57th of 454 higher than 397 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI